ORGO20260717C2.5
ORGO Jul 17 2026 2.50 Call (ORGO260717C00002500)
option OPRA

headquartered in canton, massachusetts, organogenesis inc. is a global leader in regenerative medicine, offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. organogenesis' versatile portfolio is designed to treat a variety of patients with repair and regenerative needs.